Review

Clinical review: Status epilepticus

Sarice Bassin¹, Teresa L Smith² and Thomas P Bleck³

¹Senior Resident in Neurology, Department of Neurology, University of Virginia, Charlottesville, Virginia, USA

²Neurology Critical Care Fellow and Clinical Instructor of Neurology, Department of Neurology, University of Virginia, Charlottesville, Virginia, USA

³The Louise Nerancy Eminent Scholar in Neurology and Departments of Neurology, Neurological Surgery, and Internal Medicine Director, Neuroscience Intensive Care Unit, University of Virginia, Charlottesville, Virginia, USA

author email corresponding author email

Critical Care 2002, 6:137-142doi:10.1186/cc1472

Published:	15 March 2002

Abstract

Status epilepticus (SE) has an annual incidence exceeding 100,000 cases in the United States alone, of which more than 20% result in death. Thus, increased awareness of presentation, etiologies, and treatment of SE is essential in the practice of critical care medicine. This review discusses current definitions of SE, as well as its clinical presentation and classification. The recent literature on epidemiology is reviewed, including morbidity and mortality data. An overview of the systemic pathophysiologic effects of SE is presented. Finally, significant studies on the treatment of acute SE and refractory SE are reviewed, including the use of anticonvulsants, such as benzodiazepines, and other drugs.